Virtu KCG Holdings’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $211K | Sell |
4,630
-4,705
| -50% | -$214K | 0.01% | 2095 |
|
|
2017
Q1 | $395K | Buy |
9,335
+3,561
| +62% | +$151K | 0.01% | 1605 |
|
|
2016
Q4 | $224K | Sell |
5,774
-8,353
| -59% | -$324K | 0.01% | 2434 |
|
|
2016
Q3 | $593K | Sell |
14,127
-10,217
| -42% | -$429K | 0.01% | 1195 |
|
|
2016
Q2 | $900K | Sell |
24,344
-6,810
| -22% | -$252K | 0.02% | 830 |
|
|
2016
Q1 | $1.19M | Buy |
31,154
+12,265
| +65% | +$470K | 0.03% | 489 |
|
|
2015
Q4 | $954K | Sell |
18,889
-14,132
| -43% | -$714K | 0.02% | 652 |
|
|
2015
Q3 | $1.51M | Buy |
33,021
+28,462
| +624% | +$1.3M | 0.02% | 388 |
|
|
2015
Q2 | $266K | Buy |
4,559
+793
| +21% | +$46.3K | ﹤0.01% | 1800 |
|
|
2015
Q1 | $208K | Buy |
+3,766
| New | +$208K | ﹤0.01% | 1874 |
|
|
2014
Q3 | – | Sell |
-36,178
| Closed | -$1.58M | – | 2947 |
|
|
2014
Q2 | $1.58M | Sell |
36,178
-26,913
| -43% | -$1.18M | 0.02% | 391 |
|
|
2014
Q1 | $2.63M | Buy |
+63,091
| New | +$2.63M | 0.03% | 201 |
|
|
2013
Q4 | – | Sell |
-19,286
| Closed | -$676K | – | 2853 |
|
|
2013
Q3 | $676K | Buy |
+19,286
| New | +$676K | 0.01% | 986 |
|